 Atrial Natriuretic Factor
"Atrial Natriuretic Factor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS.
| Descriptor ID |
D009320
|
| MeSH Number(s) |
D06.472.699.584.500 D12.644.548.585.500
|
| Concept/Terms |
Atrial Natriuretic Factor- Atrial Natriuretic Factor
- Auriculin
- ANP
- Natriuretic Peptides, Atrial
- ANF
- Atriopeptins
- Atrial Natriuretic Peptides
- Peptides, Atrial Natriuretic
alpha-Atrial Natriuretic Peptide- alpha-Atrial Natriuretic Peptide
- alpha Atrial Natriuretic Peptide
- ANP-(99-126)
- Atriopeptin (99-126)
- Cardionatrin I
- Atrial Natriuretic Factor (99-126)
- ANF (1-28)
- Atriopeptin (1-28)
- Atrial Natriuretic Factor (1-28)
- gamma ANP (99-126)
- alpha ANP
- Cardiodilatin (99-126)
- ANP Prohormone (99-126)
- ANF (99-126)
- ANP (1-28)
Atrial Natriuretic Factor Precursors- Atrial Natriuretic Factor Precursors
- Prepro-Cardiodilatin-Atrial Natriuretic Factor
- Prepro Cardiodilatin Atrial Natriuretic Factor
- ANF Precursors
- Cardiodilatin Precursor
- Prepro-ANP
- Prepro ANP
- Prepro-CDD-ANF
- Prepro CDD ANF
gamma-Atrial Natriuretic Peptide- gamma-Atrial Natriuretic Peptide
- gamma Atrial Natriuretic Peptide
- ANF (1-126)
- Proatrial Natriuretic Factor
- Pronatriodilatin
- Atriopeptin 126
- Cardionatrin IV
- Atrial Natriuretic Factor Prohormone
- Atrial Natriuretic Factor (1-126)
- Atrial Natriuretic Peptide (1-126)
- ANP (1-126)
- Atrial Pronatriodilatin
- Atriopeptin Prohormone (1-126)
- Atriopeptigen
- Pro-ANF
- Pro ANF
- ProANF
|
Below are MeSH descriptors whose meaning is more general than "Atrial Natriuretic Factor".
Below are MeSH descriptors whose meaning is more specific than "Atrial Natriuretic Factor".
This graph shows the total number of publications written about "Atrial Natriuretic Factor" by people in this website by year, and whether "Atrial Natriuretic Factor" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 | | 1995 | 1 | 1 | 2 | | 1996 | 1 | 0 | 1 | | 1997 | 1 | 3 | 4 | | 1998 | 1 | 0 | 1 | | 1999 | 0 | 1 | 1 | | 2000 | 0 | 1 | 1 | | 2001 | 0 | 3 | 3 | | 2002 | 0 | 3 | 3 | | 2003 | 0 | 2 | 2 | | 2004 | 1 | 1 | 2 | | 2005 | 2 | 2 | 4 | | 2006 | 1 | 2 | 3 | | 2007 | 0 | 2 | 2 | | 2009 | 0 | 1 | 1 | | 2010 | 0 | 1 | 1 | | 2011 | 1 | 0 | 1 | | 2012 | 0 | 1 | 1 | | 2014 | 0 | 1 | 1 | | 2015 | 0 | 1 | 1 | | 2016 | 0 | 1 | 1 | | 2019 | 0 | 1 | 1 | | 2022 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Atrial Natriuretic Factor" by people in Profiles.
-
Miyoshi T, Hosoda H, Miyake A, Sakaguchi H, Kitano M, Kurosaki KI, Shiraishi I, Nakai M, Nishimura K, Miyazato M, Kangawa K, Yoshimatsu J, Minamino N. Utility of perinatal natriuretic peptide for predicting neonatal heart failure. Pediatr Int. 2022 Jan; 64(1):e15231.
-
Hippensteel JA, Uchimido R, Tyler PD, Burke RC, Han X, Zhang F, McMurtry SA, Colbert JF, Lindsell CJ, Angus DC, Kellum JA, Yealy DM, Linhardt RJ, Shapiro NI, Schmidt EP. Intravenous fluid resuscitation is associated with septic endothelial glycocalyx degradation. Crit Care. 2019 07 23; 23(1):259.
-
LaRocca TJ, Altman P, Jarrah AA, Gordon R, Wang E, Hadri L, Burke MW, Haddad GE, Hajjar RJ, Tarzami ST. CXCR4 Cardiac Specific Knockout Mice Develop a Progressive Cardiomyopathy. Int J Mol Sci. 2019 May 08; 20(9).
-
Medina E, Sucharov CC, Nelson P, Miyamoto SD, Stauffer BL. Molecular Changes in Children with Heart Failure Undergoing Left Ventricular Assist Device Therapy. J Pediatr. 2017 03; 182:184-189.e1.
-
Lohani O, Colvin KL, Yeager ME. Biomarkers for pediatric pulmonary arterial hypertension: challenges and recommendations. Paediatr Respir Rev. 2015 Sep; 16(4):225-31.
-
O'Malley RG, Bonaca MP, Scirica BM, Murphy SA, Jarolim P, Sabatine MS, Braunwald E, Morrow DA. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36). J Am Coll Cardiol. 2014 Apr 29; 63(16):1644-53.
-
Lewandowski ED, Fischer SK, Fasano M, Banke NH, Walker LA, Huqi A, Wang X, Lopaschuk GD, O'Donnell JM. Acute liver carnitine palmitoyltransferase I overexpression recapitulates reduced palmitate oxidation of cardiac hypertrophy. Circ Res. 2013 Jan 04; 112(1):57-65.
-
Iconomidou VA, Pheida D, Hamodraka ES, Antony C, Hoenger A, Hamodrakas SJ. An amyloidogenic determinant in N-terminal pro-brain natriuretic peptide (NT-proBNP): Implications for cardiac amyloidoses. Biopolymers. 2012; 98(1):67-75.
-
Chen J, Chemaly ER, Liang LF, LaRocca TJ, Yaniz-Galende E, Hajjar RJ. A new model of congestive heart failure in rats. Am J Physiol Heart Circ Physiol. 2011 Sep; 301(3):H994-1003.
-
Murphy GA, Fiuzat M, Bristow MR. Targeting heart failure therapeutics: a historical perspective. Heart Fail Clin. 2010 Jan; 6(1):11-23.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|